Prostate Cancer (Adenocarcinoma) Clinical Trials in Philadelphia, Pennsylvania
2 recruitingPhiladelphia, Pennsylvania
Showing 1–2 of 2 trials
Recruiting
Phase 3
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Prostate Cancer (Adenocarcinoma)
Canadian Cancer Trials Group830 enrolled340 locationsNCT06592924
Recruiting
Not Applicable
Adaptive Radiation Therapy for Men With Intermediate- or High-Risk Prostate Cancer
Prostate Cancer (Adenocarcinoma)
Fox Chase Cancer Center80 enrolled1 locationNCT07219303